Deficiency of the interleukin-1–receptor antagonist
| Deficiency of the interleukin-1–receptor antagonist | |
|---|---|
| |
| Synonyms | Interleukin 1 receptor antagonist deficiency |
| Pronounce | |
| Field | Immunology |
| Symptoms | |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Mutations in IL1RN gene[1][2] |
| Risks | |
| Diagnosis | Genetic test, Radiological findings[3][2] |
| Differential diagnosis | |
| Prevention | |
| Treatment | Colchicine [4] |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Deficiency of the interleukin-1–receptor antagonist (DIRA) is an autosomal recessive, genetic autoinflammatory syndrome resulting from mutations in IL1RN, the gene encoding the interleukin 1 receptor antagonist.[5][6][1] The mutations result in an abnormal protein that is not secreted, exposing the cells to unopposed interleukin 1 activity. This results in sterile multifocal osteomyelitis, periostitis (inflammation of the membrane surrounding the bones), and pustulosis due to skin inflammation from birth.
[medical citation needed]
Symptoms and signs[edit | edit source]
DIRA displays a constellation of serious symptoms which include respiratory distress, as well as the following:[7][6]
- Joint swelling
- Hepatomegaly
- Osteomyelitis
- Fused cervical vertebrae
- Interstitial pulmonary abnormality
- Stomatitis
- Mouth ulcers
- Pustulosis or pustular psoriasis
- Cerebral vasculitis
- Joint pain
- Splenomegaly
Cause[edit | edit source]
Those affected with DIRA have inherited (via autosomal recessive manner) mutations in IL1RN,[1][2] a gene that encodes a protein known as interleukin 1 receptor antagonist,[8][1] The cytogenetic location of IL1RN is 2q14.1, while its 2:113,099,364-113,134,015 are the genomic coordinates[2]
Mechanism[edit | edit source]
The mechanism of deficiency of the interleukin-1–receptor antagonist affects the normal function of IL1RN gene.The protein produced by IL1RN gene prevents the normal activities of interleukin 1(alpha) and interleukin 1(beta). Therefore, the pathophysiologic immune and inflammatory responses are nullified.[2][8] Interleukin 1 receptor antagonist(IL1RN) has a total of five alleles, of those the (IL1RN*1) and (IL1RN*2) are the most common as the other alleles are seen less than 5 percent.[2]
IL-1RN binds to the same cell receptors as the inflammatory protein IL-1, and blocks its inflammatory actions. Without IL-1Ra, the body cannot control systemic inflammation that can be caused by IL-1.[9]
Diagnosis[edit | edit source]
Those affected with deficiency of the interleukin-1–receptor antagonist can have diagnosis achieved via noting an increase of erythrocyte sedimentation rate, as well as the following:[3][2]
- Genetic test
- Radiological findings
- Clinical findings
Treatment[edit | edit source]
In terms of treatment a 2013 review indicates that colchicine can be used for DIRA.[4] Additionally there are several other management options such as anakinra, which blocks naturally occurring IL-1, this according to a 2016 pediatric textbook.[10][11]
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 1.3 "Osteomyelitis, sterile multifocal, with periostitis and pustulosis - Conditions - GTR - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2017-06-11.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 "OMIM Entry - * 147679 - INTERLEUKIN 1 RECEPTOR ANTAGONIST; IL1RN". omim.org. Retrieved 2017-06-21.
- ↑ 3.0 3.1
- ↑ 4.0 4.1
- ↑ Liaison, Janet Austin, Office of Communications and Public. "Autoinflammatory Diseases". www.niams.nih.gov. Retrieved 2017-06-11.
{{cite web}}: CS1 maint: multiple names: authors list (link) - ↑ 6.0 6.1 "OMIM Entry - # 612852 - OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP". omim.org. Retrieved 2017-06-11.
- ↑ "Deficiency of interleukin-1 receptor antagonist| Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2017-06-11.
- ↑ 8.0 8.1 Reference, Genetics Home. "IL1RN gene". Genetics Home Reference. Retrieved 2017-06-12.
- ↑
- ↑
- ↑ subscription required
Further reading[edit | edit source]
External links[edit | edit source]
| Classification |
|
|---|---|
| External resources |
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
